Predicting and Responding to Emerging Viral Infections
Oct 13–16, 2025 | Crowne Plaza Geneva, Geneva, Switzerland
Scientific Organizers:
Suresh Mahalingam, Christopher F. Basler, Felicity Burt, and Alina Baum
In Person
On Demand
×
-
Oct 13–16, 2025 | Crowne Plaza Geneva, Geneva, Switzerland
Scientific Organizers: Suresh Mahalingam, Christopher F. Basler, Felicity Burt, and Alina Baum
Suresh Mahalingam
Christopher F. Basler
Felicity Burt
Alina Baum
Available Formats:
Supported by:
In Person
On Demand
***Meeting program subject to change.
Available Formats: = In Person = On DemandMonday, October 13, 2025
Fundraising
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Foyer International
Welcome Mixer
6:00–8:00 PM
Foyer International
Tuesday, October 14, 2025
Breakfast
7:30–8:30 AM
Individual Hotel
Coffee Available
8:00–8:30 AM
Foyer International
Poster Setup
8:05–8:30 AM
Zurich Ballroom
Poster Viewing
8:15–5:00 PM
Zurich Ballroom
Welcome and Keynote Address
8:30–9:30 AM
New York Ballroom
* Suresh Mahalingam, Griffith University
Session Chair
Session Chair
Maria D. Van Kerkhove, World Health Organization
Remote Presentation: Preparing For the Next Pandemic in Increasingly Complex Times
Remote Presentation: Preparing For the Next Pandemic in Increasingly Complex Times
Coffee Break
9:30–9:50 AM
Foyer International
Why Should I Trust You? Podcast Introduction
9:50–10:00 AM
New York Ballroom
Predictive Modeling and Surveillance
10:00–11:45 AM
New York Ballroom
* Debora Marks, Harvard Medical School
Session Chair
Session Chair
* Ian Brown, The Pirbright Institute
Session Chair
Session Chair
Bethan Purse, UK Centre for Ecology & Hydrology
Environmental Change and Drivers of Emergence of Vector-Borne Viruses
Environmental Change and Drivers of Emergence of Vector-Borne Viruses
Yee-Sin LEO, National Centre for Infectious Diseases
Virus Surveillance and Predictive Modeling: Insights from Singapore's Public Health Interventions
Virus Surveillance and Predictive Modeling: Insights from Singapore's Public Health Interventions
Felicity Burt, University of The Free State
Diagnosis and Surveillance of Emerging Arboviruses in Africa
Diagnosis and Surveillance of Emerging Arboviruses in Africa
Lunch
11:45–12:45 PM
Londres Ballroom
Poster Session 1
12:30–2:30 PM
Zurich Ballroom
Symposia Spotlight 1: Transformative Strategies for Viral Discovery, Diagnosis, Prediction & Response
2:30–4:30 PM
New York Ballroom
* Felicity Burt, University of The Free State
Session Chair
Session Chair
* Daniel Stephen Chertow, National Institutes of Health
Session Chair
Session Chair
J. Kenneth Wickiser, Columbia University
The Use of Pathogen-Focused Metagenomics Strategies Within the Diagnostic Network Interrogating Both Clinical and Environmental Samples for Surveillance and Discovery
The Use of Pathogen-Focused Metagenomics Strategies Within the Diagnostic Network Interrogating Both Clinical and Environmental Samples for Surveillance and Discovery
Christina M Frederick, University of Manitoba
Mpox Virus Surveillance in Regions of Central Africa at a One Health Animal-Human Interface
Mpox Virus Surveillance in Regions of Central Africa at a One Health Animal-Human Interface
Debora Marks, Harvard Medical School
How AI Can Help Predict Viral Evolution to Accelerate Vaccine and Therapeutic Design
How AI Can Help Predict Viral Evolution to Accelerate Vaccine and Therapeutic Design
Isabella Eckerle, University Hospitals of Geneva and University of Geneva
Modeling Age-Specific Innate Responses to Respiratory Viruses Using Primary Human Airway Epithelial Cells: Implications for Pandemic Preparedness
Modeling Age-Specific Innate Responses to Respiratory Viruses Using Primary Human Airway Epithelial Cells: Implications for Pandemic Preparedness
Kirsty Short, University of Queensland
The Host Response as a Novel Diagnostic Biomarker for ‘Pre-positive’ Viral Infection
The Host Response as a Novel Diagnostic Biomarker for ‘Pre-positive’ Viral Infection
Tristan Russell, UCD
Development of Metagenomic Next Generation Sequencing for the Discovery and Surveillance of Emerging and Reemerging Viruses in Ireland
Development of Metagenomic Next Generation Sequencing for the Discovery and Surveillance of Emerging and Reemerging Viruses in Ireland
Aarushi Mehrotra, Harvard Medical School
Forecasting H1N1 Influenza Pandemic and Seasonal Evolution
Forecasting H1N1 Influenza Pandemic and Seasonal Evolution
Carol de Souza Moreira, University of Notre Dame
Bayesian Latent Class Modeling to Assess Diagnostic Accuracy of Dengue, Zika, And Chikungunya Tests Across Multi-Country Studies
Bayesian Latent Class Modeling to Assess Diagnostic Accuracy of Dengue, Zika, And Chikungunya Tests Across Multi-Country Studies
Coffee Available
4:30–5:00 PM
Foyer International
Pandemic Preparedness and Response Strategies
5:00–7:00 PM
New York Ballroom
* Eskild Petersen, Roskilde University Center
Session Chair
Session Chair
* Andrea Marzi, NIAID, National Institutes of Health
Session Chair
Session Chair
Pei-Yong Shi, GSK
Remote Presenter: GSK's Role in Strengthening Pandemic Preparedness
Remote Presenter: GSK's Role in Strengthening Pandemic Preparedness
Chad J. Roy, Tulane University
Autochthonous Theta: A Refractory Index of Airborne Disease Transmissibility
Autochthonous Theta: A Refractory Index of Airborne Disease Transmissibility
Ankur Mutreja, PATH
Talk Title to be Announced
Talk Title to be Announced
Maggie Bartlett †, Global Virus Network & Johns Hopkins School of Public Health
Short Talk: Talk Title to be Announced
Short Talk: Talk Title to be Announced
Corinna Schüß †, Leipzig University
Short Talk: Rational and Computational Design of Pre-fusion Stabilized Coronavirus Glycoproteins: A Platform Approach to Pandemic Preparedness
Short Talk: Rational and Computational Design of Pre-fusion Stabilized Coronavirus Glycoproteins: A Platform Approach to Pandemic Preparedness
On Own for Dinner
7:00–8:00 PM
Wednesday, October 15, 2025
Breakfast
7:30–8:30 AM
Individual Hotel
Coffee Available
8:00–8:30 AM
Foyer International
Poster Setup
8:05–8:30 AM
Zurich Ballroom
Poster Viewing
8:15–5:00 PM
Zurich Ballroom
Keynote Address
8:30–9:30 AM
New York Ballroom
* Alina Baum, Regeneron Pharmaceuticals
Session Chair
Session Chair
Richard Hatchett, Coalition for Epidemic Preparedness Innovations, CEPI
The Future of Pandemic Preparedness
The Future of Pandemic Preparedness
Coffee Break
9:30–9:50 AM
Foyer International
Award Recipient Acknowledgement
9:50–9:55 AM
New York Ballroom
Vaccines
9:55–11:50 AM
New York Ballroom
* Kirsty Short, University of Queensland
Session Chair
Session Chair
* Maggie Bartlett, Global Virus Network & Johns Hopkins School of Public Health
Session Chair
Session Chair
Jessica Manning, Sanofi
Anticipating the Next Pandemic: Platforms, Pathogens, and Predictive Tools
Anticipating the Next Pandemic: Platforms, Pathogens, and Predictive Tools
Andrea Marzi, NIAID, National Institutes of Health
Current Filovirus Vaccine Candidates – Focus on VSV-based Vaccines
Current Filovirus Vaccine Candidates – Focus on VSV-based Vaccines
George Warimwe, University of Oxford
Combating Rift Valley Fever - ChAdOx1 Rift Valley Fever Vaccine Safety and Immunogenicity: Phase 1 Trial in Adults
Combating Rift Valley Fever - ChAdOx1 Rift Valley Fever Vaccine Safety and Immunogenicity: Phase 1 Trial in Adults
Kizzmekia S. Corbett-Helaire, Harvard T.H. Chan School of Public Health
Preparing for Future Pandemics: The Aftermath of the COVID Vaccine
Preparing for Future Pandemics: The Aftermath of the COVID Vaccine
Lunch
11:50–12:50 PM
Londres Ballroom
Poster Session 2
12:30–2:30 PM
Zurich Ballroom
Panel Discussion: Scientific Challenges & Research Strategies for Pandemic Preparedness
3:00–4:30 PM
New York Ballroom
* Jessica Manning, Sanofi
Moderator
Moderator
Scott C. Weaver, University of Texas Medical Branch
Panelist
Panelist
Richard J. Webby, St. Jude Children's Research Hospital
Panelist
Panelist
Kizzmekia S. Corbett-Helaire, Harvard T.H. Chan School of Public Health
Panelist
Panelist
Geoffrey L. Smith, Shanghai Institute for Immunity and Infection, Chinese Academy of Sciences
Panelist
Panelist
Coffee Available
4:30–5:00 PM
Foyer International
Therapeutics
5:00–7:00 PM
New York Ballroom
* Laura M Walker, Moderna
Constraining Viral Escape with mRNA-Encoded Engineered Antibodies
Constraining Viral Escape with mRNA-Encoded Engineered Antibodies
Suresh Mahalingam, Griffith University
Advancements in Drug Repurposing and New Therapeutics for Arthritogenic Alphaviruses: Tackling Acute and Chronic Disease
Advancements in Drug Repurposing and New Therapeutics for Arthritogenic Alphaviruses: Tackling Acute and Chronic Disease
* Alina Baum, Regeneron Pharmaceuticals
Filovirus Therapeutic Antibodies
Filovirus Therapeutic Antibodies
Guillermo Albericio Bonilla, CNB-CSIC
Short Talk: Plitidepsin as a Novel Antiviral Candidate Against Monkeypox Virus
Short Talk: Plitidepsin as a Novel Antiviral Candidate Against Monkeypox Virus
Walter Reichard, University of Tennessee Health Science Center
Short Talk: Efficacy of the Antiviral, BDGR-49, During Venezuelan Equine Encephalitis Infection of the Emulate Human Brain-Chip
Short Talk: Efficacy of the Antiviral, BDGR-49, During Venezuelan Equine Encephalitis Infection of the Emulate Human Brain-Chip
On Own for Dinner
7:00–8:00 PM
Thursday, October 16, 2025
Breakfast
7:30–8:30 AM
Individual Hotel
Coffee Available
8:00–8:30 AM
Foyer International
Zoonoses 1 - One Health
8:30–11:30 AM
New York Ballroom
* Stephanie Gras, La Trobe Institute For Molecular Science
Session Chair
Session Chair
* Aaron Schmidt, Harvard Medical School
Session Chair
Session Chair
Martin Groschup, Friedrich-Loeffler-Institut
Arbovirus and Zoonotic Virus Surveillance in Africa: Emphasizing a One Health Approach
Arbovirus and Zoonotic Virus Surveillance in Africa: Emphasizing a One Health Approach
Ian Brown, The Pirbright Institute
One Health Approach to Avian and Swine Influenza
One Health Approach to Avian and Swine Influenza
Chee Wah Tan, National University of Singapore
Discovery of New Filoviruses/Other Viruses in Bats in Asia
Discovery of New Filoviruses/Other Viruses in Bats in Asia
Scott C. Weaver, University of Texas Medical Branch
Re-emerging Alphaviruses: Chikungunya and Western Equine Encephalitis
Re-emerging Alphaviruses: Chikungunya and Western Equine Encephalitis
Jordan D. Dimitrov, INSERM Centre de Recherche des Cordeliers
Short Talk: System Serology Analyses of Antibody Responses in Bats to Human Pathogens
Short Talk: System Serology Analyses of Antibody Responses in Bats to Human Pathogens
Emma J Grant, La Trobe University
Short Talk: CD8+ T Cell Epitope Conservation in Emerging H5N1 Viruses Suggests Global Protection
Short Talk: CD8+ T Cell Epitope Conservation in Emerging H5N1 Viruses Suggests Global Protection
Coffee Break
9:30–9:50 AM
Foyer International
Lunch
11:30–12:30 PM
Londres Ballroom
Women in Pandemic Preparedness Networking Session
11:35–12:30 PM
Londres Ballroom
Career Roundtable
1:00–2:00 PM
Londres Ballroom
Symposia Spotlight 2: Cutting-edge Countermeasures to Combat Emerging Viral Threats
2:30–4:30 PM
New York Ballroom
* George Warimwe, University of Oxford
Session Chair
Session Chair
* Arban Domi, GeoVax Inc.
Session Chair
Session Chair
Siew-Wai Fong, A*STAR IDL
Immune Modulators in Mosquito Saliva: A New Therapeutic Target to Combat Arboviral Threats
Immune Modulators in Mosquito Saliva: A New Therapeutic Target to Combat Arboviral Threats
Akhee Jahan, Statens Serum Institute
DNA Vaccination With Inferred Ancestral Antigens: A New Strategy Against Evolving Swine Influenza Viruses
DNA Vaccination With Inferred Ancestral Antigens: A New Strategy Against Evolving Swine Influenza Viruses
Nicholas Cheang, National University of Singapore
Intranasal Dendritic Cell-Targeting Vaccine Booster Elicits Cross-Clade, Durable And Protective Systemic And Mucosal Immunity Against Sarbecoviruses Of Pandemic Potential
Intranasal Dendritic Cell-Targeting Vaccine Booster Elicits Cross-Clade, Durable And Protective Systemic And Mucosal Immunity Against Sarbecoviruses Of Pandemic Potential
Meghan Vermillion, Gilead Sciences
Obeldesivir: A Candidate Oral Post-Exposure Prophylaxis for Filovirus Outbreak Control
Obeldesivir: A Candidate Oral Post-Exposure Prophylaxis for Filovirus Outbreak Control
Mathieu Mateo, Institut Pasteur
Preclinical Development of a MOPEVAC Vaccine Against Lassa Fever in Nonhuman Primates
Preclinical Development of a MOPEVAC Vaccine Against Lassa Fever in Nonhuman Primates
Matthew Sutton, Vaccine Research Center, NIAID, NIH
Therapeutic Protection Against Multiple Encephalitic Alphaviruses By A Vaccine-Elicited Pan-Alphavirus Antibody
Therapeutic Protection Against Multiple Encephalitic Alphaviruses By A Vaccine-Elicited Pan-Alphavirus Antibody
Patrick Chun Hean Tang, Griffith University
Development of a Codon-Deoptimized Live-Attenuated Vaccine for Zika Virus: Preclinical Efficacy in Pregnant and Male Mouse Models
Development of a Codon-Deoptimized Live-Attenuated Vaccine for Zika Virus: Preclinical Efficacy in Pregnant and Male Mouse Models
Robert Abbott, University of Texas Medical Branch
Antigen Avidity Drives the Durability of the Vaccine Immune Response
Antigen Avidity Drives the Durability of the Vaccine Immune Response
Coffee Available
4:30–5:00 PM
Foyer International
Zoonoses 2 – Virus-Host Interactions
5:00–6:45 PM
New York Ballroom
* Mathieu Mateo, Institut Pasteur
Session Chair
Session Chair
* Anastasija Cupic, Icahn School of Medicine at Mount Sinai
Session Chair
Session Chair
Richard J. Webby, St. Jude Children's Research Hospital
An Unexpected Outbreak of H5N1 Influenza in Dairy Cattle
An Unexpected Outbreak of H5N1 Influenza in Dairy Cattle
Geoffrey L. Smith, Shanghai Institute for Immunity and Infection, Chinese Academy of Sciences
Host Restriction of Monkeypox Virus and Viral Evasion Strategies
Host Restriction of Monkeypox Virus and Viral Evasion Strategies
Christopher F. Basler, Icahn School of Medicine, Mt Sinai
Virus-Host Interactions of Filoviruses with a Focus on Ebola and Marburg
Virus-Host Interactions of Filoviruses with a Focus on Ebola and Marburg
Yasuo Ariumi, CCPID, Nagasaki University
Short Talk: Ebola Virus VP35 Hijacks P-body and Stress Granule Components into Inclusion Body
Short Talk: Ebola Virus VP35 Hijacks P-body and Stress Granule Components into Inclusion Body
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
New York Ballroom
Christopher F. Basler, Icahn School of Medicine, Mt Sinai
On Own for Dinner
7:00–8:00 PM
Friday, October 17, 2025
Departure
12:00–11:59 PM
Subscribe for Updates